Acquiring Company
Supernus, Inc.
Acquired Company
Supernus Pharmaceuticals
RockvilleRockvilleBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
On November 2, 2026, Indivior Pharmaceuticals announced the completion of its merger with Supernus Pharmaceuticals. Following the merger, the certificate of incorporation and bylaws of Supernus were amended and restated. This acquisition is aimed at enhancing Indivior's capabilities in addressing addiction and related health issues.
Quick answer
Supernus, Inc. is acquiring Supernus Pharmaceuticals, announced November 2, 2026. Supernus, Inc. is based in Rockville, Maryland, United States.
- How much did Supernus, Inc. pay for Supernus Pharmaceuticals?
- The deal value was not disclosed.
- What does Supernus, Inc. do?
- Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders.
- Where are Supernus, Inc. and Supernus Pharmaceuticals based?
- Supernus, Inc. is based in Rockville, Maryland, United States. Supernus Pharmaceuticals is based in Rockville, Maryland, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Nuformix proposes merger with Biovara (November 11, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
- AmyriAD acquires Recognify Life Sciences for cognition boost (October 7, 2026)
- Gland Pharma acquires 60% stake in Novelstar Pharma (October 5, 2026)
Who to call at Supernus, Inc., and when
When Supernus, Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Supernus, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Supernus, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Supernus, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Supernus, Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Supernus Pharmaceuticals?
Supernus Pharmaceuticals was acquired by Supernus, Inc., based in Rockville. The deal was reported on November 2, 2026. Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders. Supernus, Inc. is publicly traded (SUPN) and operates in Biotechnology.
When did Supernus, Inc. acquire Supernus Pharmaceuticals?
Supernus, Inc.'s acquisition of Supernus Pharmaceuticals was reported on November 2, 2026. On November 2, 2026, Indivior Pharmaceuticals announced the completion of its merger with Supernus Pharmaceuticals. Following the merger, the certificate of incorporation and bylaws of Supernus were amended and restated. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Supernus Pharmaceuticals do?
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. It is privately held, operating in Biotechnology, and is based in Rockville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.